GROWTH-STIMULATION OF T47D HUMAN-BREAST CANCER-CELLS BY THE ANTI-PROGESTIN RU486

被引：47

作者：

BOWDEN, RT ^{[1
]}

HISSOM, JR ^{[1
]}

MOORE, MR ^{[1
]}

机构：

[1] MARSHALL UNIV,SCH MED,DEPT BIOCHEM,HUNTINGTON,WV 25704

来源：

ENDOCRINOLOGY | 1989年 / 124卷 / 05期

关键词：

D O I：

10.1210/endo-124-5-2642

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2642 / 2644

页数：3

共 28 条

[1]

BARDON S, 1987, CANCER RES, V47, P1441

[2] RU486, A PROGESTIN AND GLUCOCORTICOID ANTAGONIST, INHIBITS THE GROWTH OF BREAST-CANCER CELLS VIA THE PROGESTERONE-RECEPTOR [J].

BARDON, S ;

VIGNON, F ;

CHALBOS, D ;

ROCHEFORT, H .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (04) :692-697

[3] HORMONAL-REGULATION OF ESTROGEN-RECEPTOR MESSENGER RIBONUCLEIC-ACID IN T47DCO AND MCF-7 BREAST-CANCER CELLS [J].

BERKENSTAM, A ;

GLAUMANN, H ;

MARTIN, M ;

GUSTAFSSON, JA ;

NORSTEDT, G .

MOLECULAR ENDOCRINOLOGY, 1989, 3 (01) :22-28

[4] PHENOL RED IN TISSUE-CULTURE MEDIA IS A WEAK ESTROGEN - IMPLICATIONS CONCERNING THE STUDY OF ESTROGEN-RESPONSIVE CELLS IN CULTURE [J].

BERTHOIS, Y ;

KATZENELLENBOGEN, JA ;

KATZENELLENBOGEN, BS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2496-2500

[5] LIPOPHILIC IMPURITIES, NOT PHENOLSULFONPHTHALEIN, ACCOUNT FOR THE ESTROGENIC ACTIVITY IN COMMERCIAL PREPARATIONS OF PHENOL RED [J].

BINDAL, RD ;

CARLSON, KE ;

KATZENELLENBOGEN, BS ;

KATZENELLENBOGEN, JA .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1988, 31 (03) :287-293

[6] ACTIONS OF A PROGESTOGEN ON HUMAN-BREAST CANCER-CELLS - MECHANISMS OF GROWTH-STIMULATION AND INHIBITION [J].

BRAUNSBERG, H ;

COLDHAM, NG ;

LEAKE, RE ;

COWAN, SK ;

WONG, W .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (05) :563-571

[7] STUDY OF THE CONDITIONS AND MECHANISM OF THE DIPHENYLAMINE REACTION FOR THE COLORIMETRIC ESTIMATION OF DEOXYRIBONUCLEIC ACID [J].

BURTON, K .

BIOCHEMICAL JOURNAL, 1956, 62 (02) :315-323

[8] ESTROGENS STIMULATE CELL-PROLIFERATION AND INDUCE SECRETORY PROTEINS IN A HUMAN-BREAST CANCER CELL-LINE (T47D) [J].

CHALBOS, D ;

VIGNON, F ;

KEYDAR, I ;

ROCHEFORT, H .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (02) :276-283

[9] THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN [J].

FURR, BJA ;

JORDAN, VC .

PHARMACOLOGY & THERAPEUTICS, 1984, 25 (02) :127-205

[10] DIFFERENCE BETWEEN R5020 AND THE ANTIPROGESTIN RU486 IN ANTIPROLIFERATIVE EFFECTS ON HUMAN-BREAST CANCER-CELLS [J].

GILL, PG ;

VIGNON, F ;

BARDON, S ;

DEROCQ, D ;

ROCHEFORT, H .

BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) :37-45

← 1 2 3 →